Mikrogen Diagnostik recomLine Campylobacter IgG Lateral Strip Test Kit (6272)
$550.00
Host | Quantity | Applications | Species Reactivity | Data Sheet | |
---|---|---|---|---|---|
20 Tests | Lateral Strip Assay | Campylobacter jejuni, Campylobacter coli |
SKU: 6272
Categories: Infectious Disease Test Kits and Positive Controls, MIKROGEN Products
Overview
Product Name Mikrogen Diagnostik recomLine Campylobacter IgG Lateral Strip Test Kit (6272)
Description Strip-Immunoassay with antigens produced by recombinant techniques for the detection of IgG and IgA antibodies against Campylobacter jejuni and Campylobacter coli
Product is intended for research use.
Product is intended for research use.
Target Human Campylobacter IgG
Species Reactivity Campylobacter jejuni, Campylobacter coli
Assay Type Indirect Sandwich ELISA
Applications Lateral Strip Assay
Associated Products recomWell Campylobacter IgG ELISA Kit (6204)
recomWell Campylobacter IgA ELISA Kit (6205)
recomLine Campylobacter IgA Lateral Strip Test Kit (6273)
Campylobacter jejuni IgA Control (C139A)
Campylobacter jejuni IgG Control (C139G)
Campylobacter jejuni IgM Control (C139M)
Campylobacter jejuni IgA ELISA Kit (ESR139A)
Campylobacter jejuni IgG ELISA Kit (ESR139G)
Campylobacter jejuni IgM ELISA Kit (ESR139M)
Campylobacter jejuni Antigen (BA139VS)
recomWell Campylobacter IgA ELISA Kit (6205)
recomLine Campylobacter IgA Lateral Strip Test Kit (6273)
Campylobacter jejuni IgA Control (C139A)
Campylobacter jejuni IgG Control (C139G)
Campylobacter jejuni IgM Control (C139M)
Campylobacter jejuni IgA ELISA Kit (ESR139A)
Campylobacter jejuni IgG ELISA Kit (ESR139G)
Campylobacter jejuni IgM ELISA Kit (ESR139M)
Campylobacter jejuni Antigen (BA139VS)
Properties
Background The genus Campylobacter comprises gram-negative, spiral-shaped, microaerophilic, mesophilic to thermophilic bacteria with bipolar flagella. Human Campylobacter infections are mainly food associated intestinal infections with world-wide incidence. Contaminated and insufficient cooked foods or drinking water in tropical countries are the main sources of infection. The pathogen reservoir is mainly the intestinal tract of warm-blooded wild, domestic and pet animals. Intestinal Campylobacter infections are the second most frequent enteric bacterial infections reported in Germany after enteric Salmonelloses, whereas unreported cases not reflected in the statistics probably outnumber reported cases many times over.Campylobacter jejuni is much more frequent, accounting for over 90% of cases as compared to Campylobacter coli at approx. 9%. Besides nearly asymptomatic (clinically inapparent) courses, infected persons suffer from painful gastrointestinal symptoms with sometimes bloody diarrhoea, fever, meningism and myalgias. In rare cases sequelae like postinfectious Reactive Arthritis or Guillain-Barré Syndrome may develop with onset a few weeks after the primary infection.recomLine Campylobacter is a qualitative in-vitro test for the detection of IgG and IgA antiÂÂbodies against immunodominant antigens of Campylobacter jejuni and Campylobacter coli. In cases of previous or persistent Campylobacter infection with primary diagnosis based on stool sample culturing, recomLine Campylobacter provides for identification of specific Campylobacter antibodies by means of separate lineups of different antigens produced by recombinant engineering for the purpose of clarifying postinfection complications.
Sample Type Serum, plasma, whole blood
Assay Resolution See Figure
Components
10X Wash Buffer | 100 mL |
TMB Substrate | 40 mL |
Milk Powder | 5 g |
Instuctions for Use | 1 Each |
Evaluation Form | 1 Each |
Test Strips | 2 Vials x 10 Each |
Anti-Human IgA Conjugate | 500 uL |
Specificity Information
Target ID Human Campylobacter IgG
Research Areas Infectious Disease
Application Images
Description Strip layout.
Description Test principle and procedure:
1. 1st Incubation. A test strip loaded with Campylobacter antigens is incubated with diluted serum or plasma in a dish for 1 hour.
2. Wash 3 times
3. 2nd Incubation
4. Peroxidase conjugated anti-human antibodies (IgG or IgA specific) are added. Incubate for 45 minutes.
5. Wash 3 times
6. Color reaction. 5 - 10 minutes after addition of the coloring solution, insoluble colored bands develop at the sites on the test strips occupied by antibodies.
1. 1st Incubation. A test strip loaded with Campylobacter antigens is incubated with diluted serum or plasma in a dish for 1 hour.
2. Wash 3 times
3. 2nd Incubation
4. Peroxidase conjugated anti-human antibodies (IgG or IgA specific) are added. Incubate for 45 minutes.
5. Wash 3 times
6. Color reaction. 5 - 10 minutes after addition of the coloring solution, insoluble colored bands develop at the sites on the test strips occupied by antibodies.
Description Related recombinant Campylobacter antigens
Description Test evaluation.
Patient samples from different sources were tested to assess the performance capability of recomLine Campylobacter IgG IgA. Additional data on the frequency of positive reactivity for the individual recombinant antigens are listed.
* Samples from patients with positive Campylobacter stool cultures (C. jejuni, C. coli). Blood samples were taken 0 to 40 days after the stool diagnostics, the beginning of the disease was unknown.
** Samples from patients with suspected Guillain-Barré-Syndrom (GBS) unclarified aetiology. No data on previous illnesses involving diarrhoea were known. (Testet with recomLine Campylobacter without P39)
*** Samples from patients with suspected Reactive Arthritis (ReA) unclarified aetiology. No data on previous illnesses involving diarrhoea were known.
Patient samples from different sources were tested to assess the performance capability of recomLine Campylobacter IgG IgA. Additional data on the frequency of positive reactivity for the individual recombinant antigens are listed.
* Samples from patients with positive Campylobacter stool cultures (C. jejuni, C. coli). Blood samples were taken 0 to 40 days after the stool diagnostics, the beginning of the disease was unknown.
** Samples from patients with suspected Guillain-Barré-Syndrom (GBS) unclarified aetiology. No data on previous illnesses involving diarrhoea were known. (Testet with recomLine Campylobacter without P39)
*** Samples from patients with suspected Reactive Arthritis (ReA) unclarified aetiology. No data on previous illnesses involving diarrhoea were known.
Additional Information
Additional Information Additional Mirkogen Kit Information
Handling
Storage Store at 2-8°C.
References & Data Sheet
Data Sheet Download PDF Data Sheet